Muscarinic acetylcholine receptor M3

From WikiMD's Medical Encyclopedia

Revision as of 19:24, 17 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Muscarinic acetylcholine receptor M3 (also known as M3 receptor or mAChR M3) is a type of muscarinic acetylcholine receptor that plays a crucial role in the human body. It is encoded by the human gene CHRM3.

Function[edit]

The M3 receptor is a G protein-coupled receptor that is predominantly found in the smooth muscle, glandular tissue, and the central nervous system. It is involved in various physiological processes, including smooth muscle contraction, glandular secretion, and modulation of neurotransmitter release.

Structure[edit]

The M3 receptor is a member of the muscarinic acetylcholine receptor family, which consists of five different subtypes (M1-M5). Like all G protein-coupled receptors, the M3 receptor has seven transmembrane domains, an extracellular N-terminus, and an intracellular C-terminus.

Clinical significance[edit]

Alterations in the function or expression of the M3 receptor have been implicated in various diseases, including asthma, chronic obstructive pulmonary disease (COPD), Sjögren's syndrome, and overactive bladder syndrome. Therefore, the M3 receptor is considered a potential therapeutic target for these conditions.

Pharmacology[edit]

Several drugs target the M3 receptor to treat various conditions. For example, antimuscarinic drugs like tiotropium and ipratropium are used to treat respiratory conditions such as asthma and COPD, while mirabegron is used to treat overactive bladder syndrome.

See also[edit]

References[edit]

<references />







Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.